Purchase Articles
Showing 113–128 of 145 results
-
Fewer treatment options for patients if Canada adopts New Zealand’s prescription drug policies.
$20.00 Add to cart -
Economic cost of delayed access to 14 new cancer medicines in Canada’s public drug plans.
$20.00 Add to cart -
Including off-label drug indications in HTA jeopardizes patient health and discourages innovation
Read Article -
Medical Resource Availability in Canada and 34 OECD countries: 2016 Annual Report
$20.00 Add to cart -
Medical devices and health care costs in Canada and 74 other countries, 2010 to 2015
$20.00 Add to cart -
Medical Resource Availability in Canada’s Provinces: 2016 Annual Report
$20.00 Add to cart -
Pharmacare: what are the costs for patients and taxpayers?
Read Article -
Are cost-effectiveness rules in public drug plans denying coverage to Canadians with rare disorders?
$10.00 Add to cart -
Impact of improved data protection on health costs in Canada and Japan: lessons for the TPP.
$10.00 Add to cart -
Medical devices and health care costs in Canada and 71 other countries. 2015 Annual Report.
$10.00 Add to cart -
Economic value of the utility-expansion for new cancer drugs approved in Canada from 2004 to 2014.
Read Article -
Pharma Funding for Patient Advocacy: Unethical or a Necessity?
Read Article -
Coverage for new medicines in Canada’s public drug plans, 2015.
Read Article -
Challenging drug safety alarmism with facts.
$10.00 Add to cart -
Private versus public drug coverage in Canada. 2014 Annual Report.
$10.00 Add to cart -
Private health insurance costs in Canada.
$10.00 Add to cart